Voltaren Arthritis Pain Archives - CDR

Voltaren Arthritis Pain and the Arthritis Foundation announce multi-year partnership

April 27, 2020 by Chain Drug Review Cindy McDaniel, COVID-19, GSK, Jissan Cherian, Voltaren Arthritis Pain Supplier News

WARREN, N.J.— GlaxoSmithKline recently announced a multi-year partnership with the Arthritis Foundation to support scientific research, advocacy as well as virtual resources and community connections for the more than 30 million people in America living with osteoarthritis (OA). As part of the mission for an osteoarthritis cure, Voltaren Arthritis Pain is donating 100% of profits

FDA approves GSK’s Voltaren Arthritis Pain for O-T-C use

February 18, 2020 by Chain Drug Review Franck Riot, GlaxoSmithKline, Voltaren Arthritis Pain Leading Headlines, Supplier News

WARREN, N.J. — GlaxoSmithKline announced Tuesday that the U.S. Food and Drug Administration (FDA) has approved Voltaren Arthritis Pain (diclofenac sodium topical gel, 1% (NSAID)- arthritis pain reliever) as an over-the-counter (O-T-C) product for the temporary relief of arthritis pain in the hand, wrist, elbow, foot, ankle or knee in adults (18 years and older). With